Media coverage
4
Media coverage
Title Gout Therapies Allopurinol, Febuxostat Do Not Increase Retinal Microvascular Disorder Risk Media name/outlet Consultant Live Country/Territory United States Date 25.08.16 URL ct.moreover.com/?a=57465166552&p=1gw&v=1&x=fO0sZlWILoxbqgCDomcL8Q Persons Jung-Mu Kim, Yunjung Choi Title Gout Therapies Allopurinol, Febuxostat Do Not Increase Retinal Microvascular Disorder Risk; Allopurinol and febuxostat, recently associated with significant risk of macrovascular disorders, have no increased risk of microvascular conditions. Media name/outlet Consultant Live Country/Territory United States Date 25.08.16 Persons Jung-Mu Kim, Yunjung Choi Title Gout Therapies Allopurinol, Febuxostat Do Not Increase Retinal Microvascular Disorder Risk Media name/outlet HCPLive Country/Territory United States Date 25.08.16 URL ct.moreover.com/?a=57465352545&p=1gw&v=1&x=xcDRRn4dlIVJ0BLYkmz28Q Persons Jung-Mu Kim, Yunjung Choi Title Gout Therapies Allopurinol, Febuxostat Do Not Increase Retinal Microvascular Disorder Risk Media name/outlet HCP Live Country/Territory United States Date 25.08.15 Persons Jung-Mu Kim, Yunjung Choi